 | • レポートコード：QYR9ST04523 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、末梢動脈疾患（PAD）治療薬の世界市場について調査・分析し、末梢動脈疾患（PAD）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗血小板薬、二重抗血小板療法薬、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の末梢動脈疾患（PAD）治療薬市場動向 ・主要企業別マーケットシェア ・末梢動脈疾患（PAD）治療薬の種類別市場規模2014-2019 （抗血小板薬、二重抗血小板療法薬、その他） ・末梢動脈疾患（PAD）治療薬の用途別市場規模2014-2019 （病院、診療所、その他） ・末梢動脈疾患（PAD）治療薬の北米市場：主要企業・種類別/用途別市場規模 ・末梢動脈疾患（PAD）治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・末梢動脈疾患（PAD）治療薬の中国市場：主要企業・種類別/用途別市場規模 ・末梢動脈疾患（PAD）治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・末梢動脈疾患（PAD）治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・末梢動脈疾患（PAD）治療薬のインド市場：主要企業・種類別/用途別市場規模 ・末梢動脈疾患（PAD）治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AstraZeneca Plc. (UK)、Bayer HealthCare Pharmaceuticals (Germany)、Bristol-Myers Squibb Company (US)、Merck & Co., Inc. (US)、Proteon Therapeutics, Inc. (US)、Sanofi S.A. (France)、Symic Bio, Inc. (US)、TheraVasc Inc. (US)、AnGes MG, Inc. (Japan)、Athersys, Inc. (US)、Betagenon AB (Sweden)、miRagen Therapeutics, Inc. (US)、Multi Gene Vascular Systems Ltd (Israel)、ViroMed Co. Ltd. (Korea)） ・末梢動脈疾患（PAD）治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.In 2018, the global Peripheral Arterial Disease (PAD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Peripheral Arterial Disease (PAD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peripheral Arterial Disease (PAD) Therapeutics development in United States, Europe and China.
The key players covered in this study
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Market segment by Type, the product can be split into
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Peripheral Arterial Disease (PAD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Peripheral Arterial Disease (PAD) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Peripheral Arterial Disease (PAD) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-Platelet Drugs
1.4.3 Dual Antiplatelet Therapy Drugs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size
2.2 Peripheral Arterial Disease (PAD) Therapeutics Growth Trends by Regions
2.2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Manufacturers
3.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Peripheral Arterial Disease (PAD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
5.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in United States
5.3 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
5.4 United States Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
6 Europe
6.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
6.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Europe
6.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
6.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
7 China
7.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
7.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in China
7.3 China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
7.4 China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
8 Japan
8.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
8.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Japan
8.3 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
8.4 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
9.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
9.4 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
10 India
10.1 India Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
10.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in India
10.3 India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
10.4 India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019)
11.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Central & South America
11.3 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type
11.4 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
12 International Players Profiles
12.1 AstraZeneca Plc. (UK)
12.1.1 AstraZeneca Plc. (UK) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Plc. (UK) Recent Development
12.2 Bayer HealthCare Pharmaceuticals (Germany)
12.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Development
12.3 Bristol-Myers Squibb Company (US)
12.3.1 Bristol-Myers Squibb Company (US) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Company (US) Recent Development
12.4 Merck & Co., Inc. (US)
12.4.1 Merck & Co., Inc. (US) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.4.5 Merck & Co., Inc. (US) Recent Development
12.5 Proteon Therapeutics, Inc. (US)
12.5.1 Proteon Therapeutics, Inc. (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.5.5 Proteon Therapeutics, Inc. (US) Recent Development
12.6 Sanofi S.A. (France)
12.6.1 Sanofi S.A. (France) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.6.5 Sanofi S.A. (France) Recent Development
12.7 Symic Bio, Inc. (US)
12.7.1 Symic Bio, Inc. (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.7.5 Symic Bio, Inc. (US) Recent Development
12.8 TheraVasc Inc. (US)
12.8.1 TheraVasc Inc. (US) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.8.5 TheraVasc Inc. (US) Recent Development
12.9 AnGes MG, Inc. (Japan)
12.9.1 AnGes MG, Inc. (Japan) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.9.4 AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.9.5 AnGes MG, Inc. (Japan) Recent Development
12.10 Athersys, Inc. (US)
12.10.1 Athersys, Inc. (US) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Peripheral Arterial Disease (PAD) Therapeutics Introduction
12.10.4 Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
12.10.5 Athersys, Inc. (US) Recent Development
12.11 Betagenon AB (Sweden)
12.12 miRagen Therapeutics, Inc. (US)
12.13 Multi Gene Vascular Systems Ltd (Israel)
12.14 ViroMed Co. Ltd. (Korea)
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Peripheral Arterial Disease (PAD) Therapeutics Key Market Segments
Table Key Players Peripheral Arterial Disease (PAD) Therapeutics Covered
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-Platelet Drugs Figures
Table Key Players of Anti-Platelet Drugs
Figure Dual Antiplatelet Therapy Drugs Figures
Table Key Players of Dual Antiplatelet Therapy Drugs
Figure Others Figures
Table Key Players of Others
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Peripheral Arterial Disease (PAD) Therapeutics Report Years Considered
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions 2014-2019
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions 2014-2019
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Manufacturers in 2018
Table Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Peripheral Arterial Disease (PAD) Therapeutics Product/Solution/Service
Table Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Application in 2018
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2018-2019)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2014-2019)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2019)
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2018-2019)
Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2014-2019)
Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2019)
Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2018-2019)
Table China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2014-2019)
Table China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2019)
Figure Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2018-2019)
Table Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2014-2019)
Table Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2018-2019)
Table Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2019)
Figure India Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2018-2019)
Table India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2014-2019)
Table India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2018-2019)
Table Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2014-2019)
Table Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Plc. (UK) Company Details
Table AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Plc. (UK) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table AstraZeneca Plc. (UK) Recent Development
Table Bayer HealthCare Pharmaceuticals (Germany) Company Details
Table Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure Bayer HealthCare Pharmaceuticals (Germany) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table Bayer HealthCare Pharmaceuticals (Germany) Recent Development
Table Bristol-Myers Squibb Company (US) Company Details
Table Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Company (US) Recent Development
Table Merck & Co., Inc. (US) Company Details
Table Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure Merck & Co., Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table Merck & Co., Inc. (US) Recent Development
Table Proteon Therapeutics, Inc. (US) Company Details
Table Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure Proteon Therapeutics, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table Proteon Therapeutics, Inc. (US) Recent Development
Table Sanofi S.A. (France) Company Details
Table Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi S.A. (France) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table Sanofi S.A. (France) Recent Development
Table Symic Bio, Inc. (US) Company Details
Table Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure Symic Bio, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table Symic Bio, Inc. (US) Recent Development
Table TheraVasc Inc. (US) Company Details
Table TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure TheraVasc Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table TheraVasc Inc. (US) Recent Development
Table AnGes MG, Inc. (Japan) Company Details
Table AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure AnGes MG, Inc. (Japan) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table AnGes MG, Inc. (Japan) Recent Development
Table Athersys, Inc. (US) Company Details
Table Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)(Million US$)
Figure Athersys, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Therapeutics Business (2014-2019)
Table Athersys, Inc. (US) Recent Development
Table Betagenon AB (Sweden) Company Details
Table miRagen Therapeutics, Inc. (US) Company Details
Table Multi Gene Vascular Systems Ltd (Israel) Company Details
Table ViroMed Co. Ltd. (Korea) Company Details
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Regions in 2025
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Product (2019-2025)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Product in 2025
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2025)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
クラッベ病薬の世界市場：市場規模・現状・予測 Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…- クラッベ病薬の世界市場：市場規模・現状・予測 Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- 感染症治療の世界市場：市場規模・現状・予測 Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of inf…
- アルツハイマー病治療薬の世界市場：市場規模・現状・予測 Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 重症筋無力症薬の世界市場：市場規模・現状・予測 Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and …